Literature DB >> 33880070

Outcome of Severe Traumatic Brain Injury at KSMC: Functional Outcomes of ICP Monitor Insertion-Two Years' Experience.

Abdul Raman M Al-Shudifat1,2, Babar Kahlon2, Sarah Bin Abdulqader2, Wajab Almutairi2, Khairiah Alsumali2, Yazeed Aldhfyan2, Laith Al-Abdallat1.   

Abstract

PURPOSE: To evaluate functional outcomes of severe traumatic brain injuries after insertion of intracranial pressure (ICP) monitor at King Saud Medical City (KSMC) and their correlation to each other. PATIENTS AND METHODS: A retrospective observational study for all adult patients (age >18 years) who were diagnosed with severe head injury and underwent ICP insertion at KSMC. Patients diagnosed between 2017 and 2019 were included. Data for measured outcomes, Glasgow outcome scale (GOS), Karnofsky Performance Score (KPS) and length of stay (LOS) and prognostic factors, data like: age, gender and primary Glasgow coma score (GCS) was obtained from patients' files and direct communication with patients or their caregivers. We also compared patients who underwent ICP monitoring alone with those who underwent ICP with decompressive craniectomy (DC). Follow-up period ranged from 6-24 months.
RESULTS: Seventy-four patients were included in this cohort study. Outcome measurements for patients with decompression and ICP were lower than those with ICP alone. KPS and GOS showed strong correlation (p<0.01) in whole cohort and in both subgroups (ICP alone and ICP with DC). KPS showed significant correlation with length of stay (p=0.026).
CONCLUSION: ICP monitoring is valid tool in management of severely head injured patients. Patients who underwent DC had a worse outcome. KPS can be used as alternative tool to measure functional outcome in severe traumatic brain injury.
© 2021 AL-Shudifat et al.

Entities:  

Keywords:  ICP monitoring; decompressive craniectomy; functional outcome; traumatic brain injury

Year:  2021        PMID: 33880070      PMCID: PMC8052127          DOI: 10.2147/OAEM.S288262

Source DB:  PubMed          Journal:  Open Access Emerg Med        ISSN: 1179-1500


Introduction

Traumatic brain injury (TBI) is considered as one of the most common causes of mortality in the young population. Motor vehicle accidents (MVA) are considered the main cause of severe traumatic brain injury in developing countries.7 A TBI can result in a wide spectrum of clinical picture depending on the severity, that might affect cognition, mobility, sensation, behavior, and speech.5,21 In addition, it has long-term sequelae like financial burden and social impact both on affected people and caregivers.14 Management of TBI depends on the severity of the injury. Many guidelines were described in the literature regarding management and can help in improving outcomes, with Brain Trauma Foundation (BTF) guidelines being the worldwide-adopted measures for severe head injury management.6 Intracranial pressure (ICP) monitoring is the mainstay and steering factor in these guidelines, where clear indications were established for ICP insertion. Neuroimaging and clinical examination are still used in some centers to monitor patients with severe head injury.8 The evaluation of these established guidelines need validated outcome measurements and tools. Mortality rate, neurological outcomes, hospital stay, in-hospital complications, quality of life, and functional outcome measurements like the Glasgow Outcome Scale (GOS) are currently used as outcome measurements for severe head injury management.15,17 TBI is considered a major concern in our region with significant impact on health resources and unwanted consequences on social life.11 Therefore, in this study we aim to evaluate functional outcomes after insertion of ICP for patients who suffered from severe traumatic brain injury at KSMC, the biggest referral trauma center in Saudi Arabia.

Patients and Methods

Approval was obtained from Institutional Review Board at King Saud Medical Complex, approval number H1R1-24Jun19-02. Study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained prior to study commencement from the patient himself/herself, or from a relative when patient had low GCS. Data for patients and measured outcomes (GOS, KPS, 30-day mortality rate and length of stay) for those who underwent ICP monitoring over two years at KSMC were obtained from patients’ files and direct contact with caregivers or patients themselves. The Codman Neuro device was used for intraparenchymal ICP monitoring, with continuous monitoring and recording under ICU staff control. Prognostic factors (age, gender, and primary GCS) were obtained from patients’ files. Furthermore, we divided our cohort into two subgroups: patients who underwent ICP monitoring alone and those underwent ICP with decompressive craniectomy (DC). Follow-up period was 6–24 months.

Statistical Analysis

Inclusion criteria: all patients who diagnosed with severe traumatic brain injury (GCS <8) between January 2017 and January 2019 and underwent ICP insertion at our hospital. Exclusion criteria include patients with missed follow-up after discharge. Our criteria for ICP insertion are in concordance with TBI foundation guidelines with TBI protocol for management of head injury.6 Data for patients and measured outcomes was obtained from patients’ files and direct contact with caregivers or patients themselves. We used p-value significance and Pearson's correlation between different variables, and we did not go further in multivariable because of the results in univariate analysis. Software used was SPSS.

Results

Study Population

A total of 74 patients fulfilled the inclusion criteria after exclusion of 14 patients with missed data, 47 patients were treated by ICP insertion and 27 patients treated by ICP insertion followed by decompressive craniectomy. Details of patients and injury characteristics were illustrated in Table 1. Mean age was 26.6 years (±14.7). Males (88%) were more affected than females (12%). MVA constituted the majority of admitted cases (85.1%). There was no statistically significant difference between both subgroups in age, gender and GCS at admission.
Table 1

Study Population and Subgroups Characteristics

All Patients74ICP Alone47 (63.5%)ICP + Decompressive Craniectomy27 (36.5%)p-value
AgeMean ±SD26.64±14.6926.04±12.7926.70±18.300.856
Gender0.834
 Female9 (12%)6 (13%)3 (11%)
 Male65 (88%)41 (87%)24 (89%)
KPSMedian (Range)60 (0–90)70 (0–90)60 (0–80)0.105
GOSMedian (Range)4 (1–5)4 (1–5)3 (1–4)0.248
Hospital length of stay (days)Mean ±SD66.03±99.53452.17±88.27889.00±89.000.124
Initial GCSMedian (Range)6 (3–9)7 (3–9)6 (3–8)0.115
30-day mortality0.684
 Yes12 (16%)7 (15%)5 (19%)
 No62 (84%)40 (85%)22 (81%)
Causes
 MVA63 (85.1%)41 (87.3%)22 (81.5)
 Falls7 (9.4%)4 (8.5%)3 (11.1%)
 Assault3 (4.1%)2 (4.2%)1 (3.7%)
 Gunshot1 (1.4%)0 (0%)1 (3.7%)
Study Population and Subgroups Characteristics

Outcome Measurements

All outcome measurements for the group who underwent ICP and DC were worse than those for the ICP group alone, but without statistically significant difference, see Table 1. Although its value was high (89 days), length of stay for the ICP and DC group did not show significant difference between both subgroups. Age and gender also tested for possible correlation with outcome measurements, which revealed no statistical correlation (data not shown).

Correlation Between Outcome Measurements

By using Pearson's correlation, we tested outcome measurements (GOS, KPS, length of stay) against each other for the whole group and both subgroups for possible correlation. Interestingly, KPS was strongly correlated to GOS in all groups (p<0.01). Moreover, in the ICP subgroup without decompression, KPS showed significant correlation with length of stay (p=0.026), see Table 2.
Table 2

Pearson's Correlation Between Outcome Measurements (Whole Group, ICP Group and, ICP with Decompressive Craniectomy)

GOSKPSLength of Stay
Whole group
 GOS0.0006*0.144
 KPS0.0006*0.085
 Length of stay0.1440.085
ICP group
 GOS0.0006*0.055
 KPS0.0006*0.026*
 Length of stay0.0550.026*
ICP and DC group
 GOS0.0008*0.801
 KPS0.0008*0.786
 Length of stay0.8010.786

Note: *Statistical significance (p<0.05).

Pearson's Correlation Between Outcome Measurements (Whole Group, ICP Group and, ICP with Decompressive Craniectomy) Note: *Statistical significance (p<0.05).

Discussion

Severe TBI is a major burden, affecting 10 million people per year worldwide.18,24 In Saudi Arabia most patients (56.7%) had severe TBI (GCS 3–8).3 Patients admitted with severe TBI constituted (93.2%) of the total mortality rate, MVC was the main mechanism of TBI.2–4 Our cohort, which was restricted to severe traumatic head injury in the adult population treated in our center, showed that MVA is the most common cause for severe traumatic brain injury (85.1%) with young male patients as the most affected group. Different management protocols for severe TBI were discussed in the literature. Most of these protocols use ICP monitor insertion as a guide for management, as it also proved to improve primary outcome.1,8,9 Although decompressive craniectomy was described as part of the treatment when there is refractory medical treatment for brain edema secondary to trauma, many reports were doubting its efficacy and its role in outcome improvement.17,20,22 In our center we have adopted most of the Brain Trauma Foundation (BTF) guidelines of management of severe traumatic brain injury where ICP monitor insertion and decompressive craniectomy indications were clearly stated in our protocol for many years. Our current study demonstrated, in comparison with previous literature,17,19 acceptable outcome values (KPS, GOS, length of stay) for the whole group and subgroups see Table 1. As expected, the subgroup that underwent decompressive craniectomy with ICP monitor insertion showed lower outcome values,16 owing to their low initial GCS secondary to severe primary impact injury. Neurological deficits, mortality, hospital stay, quality of life, and functional outcome were used as instruments to measure outcome of severe TBI.6,22 Functional outcome like GOS, disability indexes, and return to work were used variably in the literature to compare different treatment protocols for severe traumatic brain injury in adults.10,23 Many predicting factors were mentioned in these reports that could affect outcome like: age, initial GCS, ICP readings, etc. In our cohort, studying these factors was beyond the scope of this study, but we examined correlation of age and initial GCS with measured outcomes and they were not statistically significant. In addition, we found no statistically significant difference between both subgroups (ICP alone and ICP with DC) in age, gender and initial GCS, which made comparison of outcomes between these subgroups more reasonable. This study is one of the few studies on patients with severe TBI that used KPS as a primary outcome measurement.13,17,25 To our knowledge, most of functional outcomes were focused on GOS or its extended version (GOSE), though it has many drawbacks and critiques like crudeness, narrow scale, and no clear structured administration rules.12 KPS has more precise assessment of functional level with a wider score range. Our results showed strong correlation between GOS and KPS in the whole group and both subgroups with significant correlation between KPS and length of stay in the group with ICP monitor insertion alone, while GOS did not show any correlation with length of stay in any group. This study has many limitations like retrospective design, relatively small sample size, variable follow-up period, and limited confounders studied. However, we think that we presented our experience at one of the biggest trauma centers in Saudi Arabia focusing on functional outcome of severe traumatic brain injury in adults may trigger further investigation in this field. Furthermore, we believe that using KPS as an instrument to measure functional outcome may result in more sensitive and accurate assessment of functional level than the GOS. Consequently, KPS may be a valuable alternative to the GOS for assessing functional outcome after severe TBI in adults.

Conclusion

Severe traumatic brain injury has unwarranted effects on measured functional outcomes. ICP monitoring is a valid tool in management of severe traumatic brain injury. Patients who underwent decompressive craniectomy had a worse outcome than those treated with ICP alone. KPS can be used as an alternative tool to measure functional outcome in severe traumatic brain injury. Larger and prospective studies are recommended to test the validity of use of such a tool in evaluation of functional outcome of severe traumatic brain injury in adults.
  23 in total

1.  Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

2.  Brain Trauma Foundation Guidelines for Intracranial Pressure Monitoring: Compliance and Effect on Outcome.

Authors:  Alberto Aiolfi; Elizabeth Benjamin; Desmond Khor; Kenji Inaba; Lydia Lam; Demetrios Demetriades
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

3.  The epidemiology and impact of traumatic brain injury: a brief overview.

Authors:  Jean A Langlois; Wesley Rutland-Brown; Marlena M Wald
Journal:  J Head Trauma Rehabil       Date:  2006 Sep-Oct       Impact factor: 2.710

4.  Functional outcomes of older adults with traumatic brain injury: a prospective, multicenter analysis.

Authors:  D X Cifu; J S Kreutzer; J H Marwitz; M Rosenthal; J Englander; W High
Journal:  Arch Phys Med Rehabil       Date:  1996-09       Impact factor: 3.966

5.  Patient outcome after traumatic brain injury in high-, middle- and low-income countries: analysis of data on 8927 patients in 46 countries.

Authors:  Mary J De Silva; Ian Roberts; Pablo Perel; Phil Edwards; Michael G Kenward; Janice Fernandes; Haleema Shakur; Vikram Patel
Journal:  Int J Epidemiol       Date:  2008-09-09       Impact factor: 7.196

6.  Guideline Adherence and Outcomes in Severe Adult Traumatic Brain Injury for the CHIRAG (Collaborative Head Injury and Guidelines) Study.

Authors:  Deepak Gupta; Deepak Sharma; Nithya Kannan; Suchada Prapruettham; Charles Mock; Jin Wang; Qian Qiu; Ravindra M Pandey; Ashok Mahapatra; Hari Har Dash; James G Hecker; Frederick P Rivara; Ali Rowhani-Rahbar; Monica S Vavilala
Journal:  World Neurosurg       Date:  2016-01-13       Impact factor: 2.104

Review 7.  Understanding the neuropsychiatric consequences associated with significant traumatic brain injury.

Authors:  Shree Uddhav Bhalerao; Carly Geurtjens; Garry Robert Thomas; Christopher Ross Kitamura; Carrol Zhou; Michelle Marlborough
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

8.  A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure Trial.

Authors:  Randall M Chesnut; Thomas P Bleck; Giuseppe Citerio; Jan Classen; D James Cooper; William M Coplin; Michael N Diringer; Per-Olof Grände; J Claude Hemphill; Peter J Hutchinson; Peter Le Roux; Stephan A Mayer; David K Menon; John A Myburgh; David O Okonkwo; Claudia S Robertson; Juan Sahuquillo; Nino Stocchetti; Gene Sung; Nancy Temkin; Paul M Vespa; Walter Videtta; Howard Yonas
Journal:  J Neurotrauma       Date:  2015-08-31       Impact factor: 5.269

9.  Patterns, Types, and Outcomes of Head Injury in Aseer Region, Kingdom of Saudi Arabia.

Authors:  Ibrahim Alnaami; Shbeli Alshehri; Saeed Alghamdi; Meshal Ogran; Asim Qasem; Abdulrahman Medawi; Abdulmajeed Medawi; Saud Alshahrani; Leen Sarhan
Journal:  Neurosci J       Date:  2019-03-07

10.  Epidemiology of traumatic head injury in children and adolescents in a major trauma center in Saudi Arabia: implications for injury prevention.

Authors:  Sultan Alhabdan; Mohammed Zamakhshary; Manal AlNaimi; Hala Mandora; Manal Alhamdan; Khalid Al-Bedah; Salem Al-Enazi; Amro Al-Habib
Journal:  Ann Saudi Med       Date:  2013 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.